Clinical trials
Arrhythmias, Cardiac trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 6 |
| Recruiting | 5 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rigshospitalet, Denmark | 9 |
| Medtronic | 5 |
| Steno Diabetes Center Copenhagen | 3 |
| Herlev and Gentofte Hospital | 2 |
| Sanofi | 2 |
| Aalborg University Hospital | 1 |
| Abbott Medical Devices | 1 |
| Biosense Webster, Inc. | 1 |
| Bispebjerg Hospital | 1 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrhythmias, Cardiac | 41 |
| Atrial Fibrillation | 13 |
| Cardiovascular Diseases | 7 |
| Heart Diseases | 7 |
| Heart Failure | 7 |
| Atrial Flutter | 4 |
| Bradycardia | 4 |
| Death, Sudden, Cardiac | 4 |
| Hypoglycemia | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.